First-in-human study of naporafenib (LXH254) with or without spartalizumab in adult patients with advanced solid tumors harboring MAPK signaling pathway alterations
by Janku, Filip (Author)
, Kim, Tae Min (Author)
, Iyer, Gopakumar (Author)
, Spreafico, Anna (Author)
, Elez, Elena (Author)
, de Jonge, Maja (Author)
, Yamamoto, Noboru (Author)
, van der Wekken, Anthonie J. (Author)
, Ascierto, Paolo Antonio (Author)
, Maur, Michela (Author)
, Marmé, Frederik (Author)
, Kiladjian, Jean-Jacques (Author)
, Basu, Sumit (Author)
, Baffert, Fabienne (Author)
, Buigues, Amparo (Author)
, Chen, Chi (Author)
, Cook, Vesselina (Author)
, Giorgetti, Elisa (Author)
, Kim, Jaeyeon (Author)
, McCarthy, Fiona (Author)
, Moschetta, Michele (Author)
, Dummer, Reinhard (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource